×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
WVE – wave life sciences ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
WVE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/5
10:00 am
wve
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
High
Report
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
2/5
09:41 am
wve
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
Medium
Report
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
2/3
12:51 pm
wve
Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
Low
Report
Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
2/3
08:15 am
wve
WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..
2/2
07:41 am
wve
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]
Medium
Report
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]
2/2
07:30 am
wve
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
Medium
Report
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
1/23
05:09 am
wve
WAVE Life Sciences (NASDAQ:WVE) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
WAVE Life Sciences (NASDAQ:WVE) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/19
01:53 am
wve
Should Wave's New Obesity Data and INHBE/ALK7 Focus Require Action From Wave Life Sciences (WVE) Investors? [Yahoo! Finance]
Low
Report
Should Wave's New Obesity Data and INHBE/ALK7 Focus Require Action From Wave Life Sciences (WVE) Investors? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
MISS
Report
-11.1%
wave life sciences ltd. - ordinary shares
7/30/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
MISS
Report
-4.4%
wave life sciences ltd. - ordinary shares
5/8/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
MISS
Report
0.1%
wave life sciences ltd. - ordinary shares
3/4/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
BEAT
Report
13.4%
wave life sciences ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/5
01:40 pm
wve
Form SCHEDULE 13G Wave Life Sciences Ltd. Filed by: FMR LLC
Medium
Report
Form SCHEDULE 13G Wave Life Sciences Ltd. Filed by: FMR LLC
2/2
07:42 am
wve
Form 8-K Wave Life Sciences Ltd. For: Feb 02
Medium
Report
Form 8-K Wave Life Sciences Ltd. For: Feb 02
1/12
07:36 am
wve
Form 8-K Wave Life Sciences Ltd. For: Jan 12
Low
Report
Form 8-K Wave Life Sciences Ltd. For: Jan 12
1/6
09:30 pm
wve
Form 4 Wave Life Sciences Ltd. For: Jan 02 Filed by: Francis Chris
Low
Report
Form 4 Wave Life Sciences Ltd. For: Jan 02 Filed by: Francis Chris
12/15
05:05 pm
wve
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
12/15
04:32 pm
wve
Form 4 Wave Life Sciences Ltd. For: Dec 11 Filed by: GSK plc
Low
Report
Form 4 Wave Life Sciences Ltd. For: Dec 11 Filed by: GSK plc
12/11
06:02 am
wve
Form 424B5 Wave Life Sciences Ltd.
High
Report
Form 424B5 Wave Life Sciences Ltd.
12/11
06:02 am
wve
Form 8-K Wave Life Sciences Ltd. For: Dec 09
High
Report
Form 8-K Wave Life Sciences Ltd. For: Dec 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/16
Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen
14.5%
3/2 Form POS AM Wave Life Sciences Ltd. 10.1%
10/26 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.7%
2/13 Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 7.4%
4/24 Wave Life Sciences to return $7.2 mln PPP loan [Reuters] 7.4%
3/3 Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT [Yahoo! Finance News] 6.7%
8/29 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.7%
7/29 Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update 5.7%
10/19 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%
5/24 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
3/2 Form POS AM Wave Life Sciences Ltd. 10.1%
10/26 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.7%
2/13 Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 7.4%
4/24 Wave Life Sciences to return $7.2 mln PPP loan [Reuters] 7.4%
3/3 Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT [Yahoo! Finance News] 6.7%
8/29 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.7%
7/29 Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update 5.7%
10/19 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%
5/24 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
TOP News Decliners
12/16
Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy
-55.3%
12/30 Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease -49.5%
12/16 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -9.8%
2/20 Form 4 Wave Life Sciences Ltd. For: Feb 18 Filed by: Vargeese Chandra -8.5%
1/10 Form 8-K Wave Life Sciences Ltd. For: Jan 09 -8.4%
3/7 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -6.5%
3/2 Q4/2019 12/31/2019 EPS -1.650 ZacksConsensus -1.480 ActVsEst (0.170) - Miss -6.0%
9/6 Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 -5.5%
5/20 Wave Life Sciences Ltd (NASDAQ: WVE) had its price target lowered by analysts at SunTrust Banks, Inc. to $39.00. They now have a "buy" rating on the stock. -4.9%
10/7 Form 8-K Wave Life Sciences Ltd. For: Oct 07 -4.0%
12/30 Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease -49.5%
12/16 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -9.8%
2/20 Form 4 Wave Life Sciences Ltd. For: Feb 18 Filed by: Vargeese Chandra -8.5%
1/10 Form 8-K Wave Life Sciences Ltd. For: Jan 09 -8.4%
3/7 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -6.5%
3/2 Q4/2019 12/31/2019 EPS -1.650 ZacksConsensus -1.480 ActVsEst (0.170) - Miss -6.0%
9/6 Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 -5.5%
5/20 Wave Life Sciences Ltd (NASDAQ: WVE) had its price target lowered by analysts at SunTrust Banks, Inc. to $39.00. They now have a "buy" rating on the stock. -4.9%
10/7 Form 8-K Wave Life Sciences Ltd. For: Oct 07 -4.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: